Oligosaccharides in Infant Nutrition

Oligosaccharides in Infant Nutrition Market Outlook

The global oligosaccharides market is poised to reach approximately USD 5 billion by 2035, growing at a compound annual growth rate (CAGR) of around 10% during the forecast period of 2025 to 2035. The increasing demand for functional foods, coupled with the rising awareness about the health benefits of oligosaccharides in infant nutrition, is expected to be a significant growth driver for this market. As parents become more health-conscious and informed about nutritional requirements for their infants, the incorporation of oligosaccharides into infant formula and baby food is witnessing a noticeable rise. Moreover, the growing trend of preventive healthcare and the rising prevalence of gastrointestinal disorders among infants are also contributing to the increasing adoption of oligosaccharides. This trend is further bolstered by the advancements in food technology, which enable the effective integration of oligosaccharides into various infant nutrition products.

Growth Factor of the Market

One of the primary growth factors driving the oligosaccharides market in infant nutrition is the increasing awareness among parents about the importance of gut health in infants. Research has shown that oligosaccharides can play a crucial role in promoting healthy gut microbiota, which is vital for the overall development and immune system of infants. Additionally, the ability of oligosaccharides to enhance the absorption of nutrients in infants contributes to their growing popularity among manufacturers of infant nutrition products. Furthermore, the rise in disposable incomes and changing lifestyles have enabled families to spend more on premium quality baby food, which often includes functional ingredients like oligosaccharides. The growing trend of organic and clean-label products also significantly motivates manufacturers to formulate products that are enriched with natural oligosaccharides. Lastly, the increasing incidence of lactose intolerance among children has led to a shift towards oligosaccharides as a suitable alternative, further fueling market growth.

Key Highlights of the Market

• The oligosaccharides market in infant nutrition is experiencing significant growth, with a projected CAGR of 10% from 2025 to 2035.
• Galacto-oligosaccharides are expected to dominate the product type segment due to their health benefits for infants.
• Online stores are becoming a preferred distribution channel for parents seeking convenient purchasing options for infant nutrition products.
• The increasing trend of organic and clean-label products is influencing manufacturers to incorporate natural oligosaccharides.
• Geographically, North America is expected to hold a substantial share of the market, driven by high consumer awareness and health standards.

By Product Type

Galacto-oligosaccharides:

Galacto-oligosaccharides (GOS) are a prominent type of oligosaccharides utilized in infant nutrition. They are derived from lactose and are known for their prebiotic properties, which promote the growth of beneficial gut bacteria like Bifidobacteria. GOS play a vital role in enhancing digestive health and supporting immune function in infants. Their application in infant formulas is particularly significant, as they mimic the oligosaccharides found in human breast milk, thereby providing similar benefits. The increasing focus on gut health and the rising incidence of gastrointestinal issues in infants are propelling the demand for GOS in the market.

Fructo-oligosaccharides:

Fructo-oligosaccharides (FOS) are another major segment in the oligosaccharides market, known for their ability to enhance digestive health and support the immune system. They are derived from fruits and vegetables and are used as a dietary fiber supplement in various infant nutrition products. FOS are particularly favored due to their ability to improve mineral absorption, which is crucial for the growth and development of infants. Their increasing application in baby foods and nutritional supplements is also indicative of the growing consumer demand for products that promote overall health.

Mano-oligosaccharides:

Mano-oligosaccharides (MOS) are less common than GOS and FOS but are gaining traction in the infant nutrition market. They are derived from the cell walls of yeast and are known for their immunomodulatory effects. MOS can help inhibit pathogenic bacteria in the gut, thereby promoting a healthier gastrointestinal environment for infants. Their incorporation into infant formulas and supplements aids in enhancing the immune response, which is particularly beneficial for infants with underdeveloped immune systems. The increasing awareness of their health benefits is contributing to the growing demand for MOS in infant nutrition products.

Xylo-oligosaccharides:

Xylo-oligosaccharides (XOS) are recognized for their prebiotic effects and their ability to improve gut health. Derived from xylan, a component of plant cell walls, XOS enhances the growth of beneficial gut bacteria, leading to improved digestion and nutrient absorption in infants. Their mild taste makes them suitable for incorporation into a variety of infant food products, including formulas and snacks. As parents increasingly seek healthier options for their children, the demand for XOS in infant nutrition is anticipated to rise, driven by its potential to support the overall health and well-being of infants.

Isomalto-oligosaccharides:

Isomalto-oligosaccharides (IMO) are a group of oligosaccharides produced from starch through enzymatic processes. They are often used as a sugar substitute due to their low-calorie content and prebiotic properties. In the context of infant nutrition, IMO can help promote a healthy digestive system while providing a sweet taste without the calories associated with traditional sugars. Their incorporation into various products such as baby food and nutritional supplements is becoming increasingly common as manufacturers seek to offer healthier options without compromising on taste.

By Application

Infant Formula:

Infant formula is one of the leading applications of oligosaccharides, primarily due to the need for alternative nutrition sources for infants who are not breastfed. Oligosaccharides added to infant formula can replicate some of the prebiotic effects of human breast milk, promoting healthy gut flora and enhancing immune function. The growing reliance on formula feeding, coupled with increasing consumer awareness regarding infant nutrition, is driving the demand for oligosaccharides in this segment. Additionally, manufacturers are increasingly focusing on developing formulas enriched with a blend of various oligosaccharides to maximize health benefits.

Baby Food:

The baby food sector is witnessing a surge in the incorporation of oligosaccharides, driven by parents' desire for nutritious and functional food options for their children. Oligosaccharides enhance the texture and palatability of baby food products while also contributing to digestive health. The demand for organic and natural ingredients is further motivating manufacturers to formulate baby food products that include oligosaccharides as a key ingredient. This trend aligns with the broader consumer shift towards health-conscious products, making oligosaccharides a valuable addition to the baby food segment.

Nutritional Supplements:

Nutritional supplements for infants are increasingly incorporating oligosaccharides due to their beneficial properties. These supplements aim to provide additional nutritional support and enhance the overall health of infants, particularly those with special dietary needs or health concerns. Oligosaccharides can aid in improving gut health and boosting immunity, making them a popular choice among parents seeking comprehensive nutritional solutions for their children. The growing market for pediatric nutritional supplements is fueling the demand for oligosaccharides, as they are recognized for their functional benefits.

Dairy Products:

Dairy products are another significant application area for oligosaccharides, particularly in the formulation of infant yogurts and fortified milk products. The incorporation of oligosaccharides in dairy products not only enhances their nutritional profile but also improves their digestibility. With the increasing popularity of functional dairy products, manufacturers are looking to enrich their offerings with oligosaccharides to cater to health-conscious consumers. The ability of oligosaccharides to promote gut health and support immune function makes them an appealing ingredient in the dairy segment.

Bakery & Confectionery:

The bakery and confectionery segment is also beginning to embrace the use of oligosaccharides as healthier alternatives to traditional sugars. Products such as biscuits, cookies, and snacks are increasingly being formulated with oligosaccharides to offer lower-calorie options that maintain taste while providing functional health benefits. This trend is particularly appealing to parents who are looking for healthier snack options for their children. The incorporation of oligosaccharides in bakery and confectionery products aligns with the broader trend of reducing sugar intake, thereby fostering growth within this market segment.

By Distribution Channel

Online Stores:

Online stores are emerging as a dominant distribution channel for oligosaccharides in infant nutrition, driven by the growing trend of e-commerce and digital shopping. Parents are increasingly turning to online platforms for the convenience of purchasing infant nutrition products without the need to visit physical stores. The availability of a wide variety of products and the ease of comparing prices are compelling factors that encourage online shopping. As a result, many manufacturers are enhancing their online presence and leveraging digital marketing strategies to reach consumers directly, thereby boosting sales in this channel.

Supermarkets/Hypermarkets:

Supermarkets and hypermarkets continue to be prominent distribution channels for oligosaccharides in infant nutrition, as they offer a vast range of products under one roof. These retail formats provide parents with the convenience of shopping for various infant nutrition items in a single trip. The presence of knowledgeable staff and promotional activities often conducted in these stores also aids in educating consumers about the benefits of oligosaccharides, ultimately influencing purchasing decisions. As health and wellness trends gain traction, supermarkets and hypermarkets are increasingly dedicating shelf space to functional foods, including oligosaccharide-enriched products.

Specialty Stores:

Specialty stores focusing on health foods and organic products are gaining traction in the oligosaccharides market for infant nutrition. These stores often curate a selection of high-quality, niche products that appeal to health-conscious parents seeking specific dietary options for their children. The emphasis on organic and clean-label products aligns with the growing demand for natural ingredients, making specialty stores an attractive channel for oligosaccharides. Additionally, staff in these stores tend to be more knowledgeable about the products they sell, thus providing valuable information to consumers seeking to make informed choices.

Convenience Stores:

Convenience stores are experiencing growth in the sale of oligosaccharides in infant nutrition due to their accessibility and extended hours. Parents often seek quick and convenient shopping options, particularly for last-minute purchases of baby food and nutritional products. The rising trend of snacking among infants also prompts convenience stores to stock a variety of snack options enriched with oligosaccharides. While convenience stores may not offer the extensive range found in larger retailers, their strategic locations make them an essential distribution channel for impulse purchases of infant nutrition products.

Pharmacies:

Pharmacies are gaining significance as a distribution channel for oligosaccharides in infant nutrition, particularly for specialized products aimed at infants with health concerns. Parents often turn to pharmacies for nutritional supplements and specialized infant formulas that are not readily available in conventional retail outlets. The expertise of pharmacy staff in providing health-related information supports parents in selecting the right products for their infants. As the market for pediatric nutritional supplements continues to grow, pharmacies will likely play an increasingly important role in the distribution of oligosaccharides.

By Ingredient Type

Human Milk Oligosaccharides:

Human milk oligosaccharides (HMOs) are a vital ingredient type in the oligosaccharides market for infant nutrition, as they are naturally occurring in human breast milk. HMOs play a significant role in promoting healthy gut microbiota and protecting infants from infections and diseases. They are increasingly being incorporated into infant formulas to mimic the nutritional profile of breast milk, offering similar benefits to formula-fed babies. The growing acceptance and demand for HMO-enriched products reflect a shift towards enhancing the nutritional quality of infant formulas, thus driving growth in this segment.

Plant-based Oligosaccharides:

Plant-based oligosaccharides, derived from sources such as fruits, vegetables, and legumes, are becoming popular in the infant nutrition space due to their natural and wholesome appeal. These oligosaccharides are often incorporated into baby food and snacks, providing essential dietary fibers and promoting healthy digestion. As more parents seek organic and plant-based options for their children, the demand for plant-based oligosaccharides is expected to rise. This trend aligns with the broader movement towards clean-label products with minimal processing and natural ingredients.

Dairy-based Oligosaccharides:

Dairy-based oligosaccharides are derived from lactose and are primarily used in infant formulas and dairy products. They offer similar benefits to human milk oligosaccharides, contributing to digestive health and immunity support. The incorporation of dairy-based oligosaccharides in infant nutrition products caters to the increasing consumer preference for dairy-derived ingredients, reflecting a growing trend towards natural sources. As the market expands, dairy-based oligosaccharides will continue to be a key ingredient, particularly in formulations aimed at providing a balanced nutritional profile for infants.

Synthetic Oligosaccharides:

Synthetic oligosaccharides are manufactured through chemical means and are often used in infant nutrition products as a cost-effective alternative to naturally derived options. While they may not offer the same health benefits as their natural counterparts, synthetic oligosaccharides can still provide functional advantages, such as improved texture and stability in formulations. The growing demand for cost-effective solutions in the infant nutrition market is expected to drive the growth of synthetic oligosaccharides, particularly as manufacturers look for ways to optimize their production processes.

Others:

The "Others" category in ingredient types encompasses various novel oligosaccharides derived from alternative sources, including seaweed and other plants. These emerging ingredients are being researched for their potential health benefits and applications in infant nutrition. As the market evolves, the exploration of new sources of oligosaccharides is likely to expand, offering manufacturers innovative options to enhance their product formulations. The increasing interest in functional foods and dietary supplements among consumers will drive the demand for these unique ingredient types in the infant nutrition segment.

By Region

The North American region is anticipated to hold a significant share of the oligosaccharides market in infant nutrition, owing to the high awareness of infant health and nutrition standards among parents. The market is fueled by the presence of numerous key players and their consistent efforts to innovate and introduce new products enriched with oligosaccharides. The growth rate for this region is projected at a CAGR of 9% between 2025 and 2035, driven by the increasing reliance on infant formulas and baby foods that incorporate functional ingredients. Furthermore, the stringent regulatory frameworks in the region ensure high-quality standards, further boosting consumer confidence in oligosaccharide-enriched products.

In Europe, the oligosaccharides market is also witnessing substantial growth, driven by a rising emphasis on organic and clean-label products. The European market reflects a growing trend towards health-conscious consumption, with a significant number of parents opting for products that promote gut health and overall well-being. The increased availability of oligosaccharide-enriched baby food and nutritional supplements in supermarkets and specialty stores is further propelling market growth. While North America leads the market share, Europe is catching up rapidly, indicating a strong competitive landscape in the oligosaccharides segment for infant nutrition.

Opportunities

One of the most promising opportunities in the oligosaccharides market for infant nutrition lies in the growing trend of clean-label and organic products. As consumers become more health-conscious and seek transparency in food sourcing and production, manufacturers have the chance to capitalize on this trend by developing products that are not only enriched with oligosaccharides but also made from organic and natural ingredients. This alignment with consumer preferences will not only enhance brand loyalty but also expand market share among health-focused demographics. Furthermore, the demand for alternative nutrition sources for infants, especially in regions with lower breastfeeding rates, presents a significant opportunity for manufacturers to innovate and cater to this segment.

Additionally, the increasing prevalence of dietary restrictions and health conditions such as lactose intolerance among infants offers a potential growth avenue for oligosaccharides. Parents are increasingly seeking functional ingredients that promote digestive health and support the immune system, creating a gap in the market for specialized products. Companies that can effectively position their oligosaccharide-enriched products as solutions to these health concerns will likely see increased consumer interest and sales. Moreover, emerging markets in Asia Pacific and Latin America are witnessing a rising middle class with increased spending power, further contributing to the demand for high-quality infant nutrition products that incorporate oligosaccharides.

Threats

The oligosaccharides market for infant nutrition is not without its challenges and threats. One significant concern is the potential for negative perceptions regarding synthetic ingredients among consumers who prioritize natural and organic products. While synthetic oligosaccharides can offer cost advantages, manufacturers must tread carefully to ensure that their marketing communications emphasize the safety and efficacy of these ingredients. Additionally, strict regulatory requirements surrounding infant nutrition products, particularly regarding labeling and health claims, pose challenges for manufacturers trying to navigate complex compliance landscapes. Failure to adhere to these regulations can result in legal penalties, product recalls, and damage to brand reputation.

Another threat to the market is the intense competition among key players, which can lead to price wars and reduced profit margins. As more companies enter the oligosaccharides market, particularly in the infant nutrition segment, differentiation becomes crucial for establishing a competitive edge. Companies that fail to innovate or provide unique value propositions may struggle to maintain their market share, particularly as consumer preferences continue to evolve. Additionally, changing consumer trends and preferences can pose a risk to established products, necessitating constant market research and adaptation to ensure ongoing relevance in a dynamic market.

Competitor Outlook

• DuPont Nutrition & Biosciences
• FrieslandCampina
• Abbott Laboratories
• Royal FrieslandCampina
• Ginkgo BioWorks
• Fonterra Co-operative Group
• Nestlé S.A.
• Danone S.A.
• Synlogic, Inc.
• Bifidobacterium longum
• Ingredion Incorporated
• Archer Daniels Midland Company
• Fonterra Co-operative Group Limited
• Bifidobacterium longum
• Newlight Technologies

The competitive landscape of the oligosaccharides market in infant nutrition is characterized by the presence of both established players and emerging companies striving to capitalize on the growing demand for functional ingredients. Major corporations such as DuPont Nutrition & Biosciences and FrieslandCampina are at the forefront of innovation, continually investing in research and development to create new oligosaccharide formulations that cater to changing consumer preferences. These companies often leverage their extensive experience and resources to maintain leadership in the market, providing high-quality products that meet regulatory standards. Furthermore, strategic partnerships and collaborations among key players also play a significant role in driving market growth by enabling them to expand their product offerings and reach new customer segments.

In contrast, smaller companies are positioning themselves as niche players by specializing in specific types of oligosaccharides or targeting particular market segments, such as organic or plant-based products. These emerging companies often rely on agility and innovation to differentiate themselves in the competitive landscape. By focusing on unique selling propositions, such as enhanced health benefits or sustainable sourcing, they are attracting health-conscious consumers seeking alternatives to traditional infant nutrition products. As the market evolves, the interplay between established and emerging players will shape the future trajectory of the oligosaccharides market in infant nutrition.

Several key companies are noteworthy within this competitive landscape. For instance, Abbott Laboratories is renowned for its extensive range of infant formula products enriched with oligosaccharides. The company’s research-driven approach allows it to remain at the forefront of innovation in the market. Similarly, Nestlé S.A. has been a pioneer in developing oligosaccharide-enriched baby foods, leveraging its brand strength and distribution networks to capture significant market share. On the other hand, smaller players like Ginkgo BioWorks are making strides by focusing on biotechnology and sustainable practices to produce novel oligosaccharides, signifying the growing importance of sustainability in consumer preferences. As competition intensifies, collaboration and strategic investments in research and development will be crucial for companies seeking to secure their position in this dynamic market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Danone S.A.
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Synlogic, Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Ginkgo BioWorks
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 FrieslandCampina
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Nestlé S.A.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Abbott Laboratories
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Newlight Technologies
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Bifidobacterium longum
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Ingredion Incorporated
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Royal FrieslandCampina
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Fonterra Co-operative Group
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Archer Daniels Midland Company
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 DuPont Nutrition & Biosciences
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Fonterra Co-operative Group Limited
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Oligosaccharides in Infant Nutrition Market, By Application
    • 6.1.1 Infant Formula
    • 6.1.2 Baby Food
    • 6.1.3 Nutritional Supplements
    • 6.1.4 Dairy Products
    • 6.1.5 Bakery & Confectionery
  • 6.2 Oligosaccharides in Infant Nutrition Market, By Product Type
    • 6.2.1 Galacto-oligosaccharides
    • 6.2.2 Fructo-oligosaccharides
    • 6.2.3 Mano-oligosaccharides
    • 6.2.4 Xylo-oligosaccharides
    • 6.2.5 Isomalto-oligosaccharides
  • 6.3 Oligosaccharides in Infant Nutrition Market, By Ingredient Type
    • 6.3.1 Human Milk Oligosaccharides
    • 6.3.2 Plant-based Oligosaccharides
    • 6.3.3 Dairy-based Oligosaccharides
    • 6.3.4 Synthetic Oligosaccharides
    • 6.3.5 Others
  • 6.4 Oligosaccharides in Infant Nutrition Market, By Distribution Channel
    • 6.4.1 Online Stores
    • 6.4.2 Supermarkets/Hypermarkets
    • 6.4.3 Specialty Stores
    • 6.4.4 Convenience Stores
    • 6.4.5 Pharmacies

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Oligosaccharides in Infant Nutrition Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Oligosaccharides in Infant Nutrition market is categorized based on

By Product Type

• Galacto-oligosaccharides
• Fructo-oligosaccharides
• Mano-oligosaccharides
• Xylo-oligosaccharides
• Isomalto-oligosaccharides

By Application

• Infant Formula
• Baby Food
• Nutritional Supplements
• Dairy Products
• Bakery & Confectionery

By Distribution Channel

• Online Stores
• Supermarkets/Hypermarkets
• Specialty Stores
• Convenience Stores
• Pharmacies

By Ingredient Type

• Human Milk Oligosaccharides
• Plant-based Oligosaccharides
• Dairy-based Oligosaccharides
• Synthetic Oligosaccharides
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• DuPont Nutrition & Biosciences
• FrieslandCampina
• Abbott Laboratories
• Royal FrieslandCampina
• Ginkgo BioWorks
• Fonterra Co-operative Group
• Nestlé S.A.
• Danone S.A.
• Synlogic, Inc.
• Bifidobacterium longum
• Ingredion Incorporated
• Archer Daniels Midland Company
• Fonterra Co-operative Group Limited
• Bifidobacterium longum
• Newlight Technologies